ENDO HEALTH SOLUTIONS INC | 26,272 Euro | +0,226 +0,87 % | |
| WKN: 940110 ISIN: US29264F2056 Ticker-Symbol: EPV | Frankfurt | 25.05.12 | 18:07 Uhr |
Branche PharmaAktienmarkt NASDAQ BiotechS&P MidCap 400 |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 25.05. | Endo Health Solutions Inc. to Present at Jefferies 2012 Global Healthcare Conference | 53 | PR Newswire | |
| CHADDS FORD, Pa., May 25, 2012 /PRNewswire/ --Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer, will present a corporate overview at the Jefferies... Mehr lesen zu: Endo Health Solutions Inc. to Present at Jefferies 2012 Global Healthcare Conference | ||||
| 25.05. | Endo Health Solutions Inc. to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference | 54 | PR Newswire | |
| CHADDS FORD, Pa., May 25, 2012 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer, will present a corporate... Mehr lesen zu: Endo Health Solutions Inc. to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference | ||||
| 23.05. | Endo Health Solutions Inc. Announced as New Name for Endo Pharmaceuticals Holdings Inc. | 33 | PR Newswire | |
| CHADDS FORD, Pa., May 23, 2012 /PRNewswire-FirstCall/ -- Shareholders of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) voted today at its annual shareholders meeting to approve changing the company's... Mehr lesen zu: Endo Health Solutions Inc. Announced as New Name for Endo Pharmaceuticals Holdings Inc. | ||||
| 04.05. | Endo to Present at Bank of America Merrill Lynch 2012 Health Care Conference | 23 | PR Newswire | |
| CHADDS FORD, Pa., May 4, 2012 /PRNewswire/ -- Endo (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer, will present a corporate overview at the Bank... Mehr lesen zu: Endo to Present at Bank of America Merrill Lynch 2012 Health Care Conference | ||||
| 02.05. | Endo Pharma Misses, Backs View | - | Zacks | |
| 02.05. | Downgrade Alert for Endo Pharmaceuticals | - | SmarTrend | |
| 01.05. | Endo Pharmaceuticals Holdings Goes Negative | - | Motley Fool | |
| 01.05. | Endo Pharmaceuticals Holdings' CEO Discusses Q1 2012 Results - Earnings Call Transcript | - | Seeking Alpha | |
| 01.05. | Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel | 78 | PR Newswire | |
| CHADDS FORD, Pa., May 1, 2012 /PRNewswire/ --
Total quarterly revenues of $691 million, increased 23 percent versus prior year; Driven by full quarter addition of AMS as well as Qualitest revenue... Mehr lesen zu: Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel | ||||
| 17.04. | Endo Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 1, 2012 | 14 | PR Newswire | |
| CHADDS FORD, Pa., April 17, 2012 /PRNewswire/ -- Endo Pharmaceuticals Holdings (Nasdaq: ENDP) will announce its first quarter 2012 financial results on May 1, 2012 and will host a conference call... Mehr lesen zu: Endo Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 1, 2012 | ||||
| 16.04. | Equity Research on Endo Pharmaceuticals Holdings Inc. and Allergan Inc. - Drug Manufacturers Acquiring and Expanding | 55 | MarketWire | |
| NEW YORK, NY -- (Marketwire) -- 04/16/12 -- www.shinesrooms.com has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members... Mehr lesen zu: Equity Research on Endo Pharmaceuticals Holdings Inc. and Allergan Inc. - Drug Manufacturers Acquiring and Expanding | ||||
| 10.04. | Critical Alerts for Sina, CF Industries, AOL, News Corp., and Endo Pharmaceuticals by Seven Summits Research | 29 | PR Newswire | |
| CHICAGO, April 10, 2012 /PRNewswire/ --Seven Summits Research issues critical PriceWatch Alerts for SINA, CF, AOL, NWSA, and ENDP.
To see what our analysts have discovered about these stocks read... Mehr lesen zu: Critical Alerts for Sina, CF Industries, AOL, News Corp., and Endo Pharmaceuticals by Seven Summits Research | ||||
| 29.03. | Endo Announces Departure of American Medical Systems President | 58 | PR Newswire | |
| CHADDS FORD, Pa., March 29, 2012 /PRNewswire/ -- Endo (Nasdaq: ENDP) announced today that American Medical Systems' (AMS) Group President, Tony Bihl, will step down as head of the Endo devices operating... Mehr lesen zu: Endo Announces Departure of American Medical Systems President | ||||
| 22.03. | Endo Buys US Patent For Oxymorphone From Johnson Matthey | 58 | AFX News | |
| LONDON (dpa-AFX) - Endo Pharmaceuticals Holdings (ENDP) said it has acquired
U.S. patent for oxymorphone hydrochloride, the key API in all formulations of
OPANA, from Johnson Matthey plc... Mehr lesen zu: Endo Buys US Patent For Oxymorphone From Johnson Matthey | ||||
| 22.03. | Endo (ENDP) Acquires Patent for Key API in All OPANA Formulations | - | StreetInsider.com | |
| 22.03. | Endo Acquires Johnson Matthey's Oxymorphone Patent | 20 | PR Newswire | |
| CHADDS FORD, Pa., March 22, 2012 /PRNewswire/ -- Endo (Nasdaq: ENDP) announced today that it has acquired U.S. patent 7,851,482 B2 for oxymorphone hydrochloride, the key API in all formulations... Mehr lesen zu: Endo Acquires Johnson Matthey's Oxymorphone Patent | ||||
| 13.03. | Endo Pharma Files Amendment To Its Citizen Petition With FDA | 63 | AFX News | |
| WASHINGTON (dpa-AFX) - Endo Pharmaceuticals (ENDP) said it has filed an
amendment to its Citizen Petition with the FDA calling on FDA to publicly
address numerous concerns raised by Endo... Mehr lesen zu: Endo Pharma Files Amendment To Its Citizen Petition With FDA | ||||
| 13.03. | Endo Pharma (ENDP) Amends CP for Generic LIDODERM; Highlights Growing Sector Support | - | StreetInsider.com | |
| 13.03. | Endo Files Amended Citizen Petition Seeking Public FDA Resolution of Several Safety and Efficacy Issues Prior to Approval of a Generic Formulation of LIDODERM® | 12 | PR Newswire | |
| CHADDS FORD, Pa., March 13, 2012 /PRNewswire-FirstCall/ --Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it has filed an amendment to its Citizen Petition (CP) with the U.S. Food and Drug... Mehr lesen zu: Endo Files Amended Citizen Petition Seeking Public FDA Resolution of Several Safety and Efficacy Issues Prior to Approval of a Generic Formulation of LIDODERM® | ||||
| 07.03. | Harris & Harris' Portfolio Company Mersana To Collaborate With Endo Pharma | 53 | AFX News | |
| WASHINGTON (dpa-AFX) - Harris & Harris Group, Inc. (TINY), an investor in
nanotechnology companies, said Wednesday that its portfolio company, Mersana
Therapeutics Inc. has signed a collaboration... Mehr lesen zu: Harris & Harris' Portfolio Company Mersana To Collaborate With Endo Pharma | ||||
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
